Mar 31, 2022

Encompass Health Q1 2022 Earnings Report

Encompass Health's Q1 2022 results demonstrated robust demand for its services, with revenue growth driven by volume in both segments, but were impacted by strategic alternatives review costs and stock-based compensation.

Key Takeaways

Encompass Health reported strong demand for its services in Q1 2022, with revenue growth primarily driven by volume in both the inpatient rehabilitation and home health and hospice segments. The company reaffirmed its full-year 2022 guidance.

Revenue growth in Q1 2022 resulted primarily from volume growth in both segments.

Income from continuing operations attributable to Encompass Health per diluted share in Q1 2022 was impacted by higher costs associated with the strategic alternatives review and higher stock-based compensation.

Cash flows provided by operating activities increased 38.1% in Q1 2022.

Adjusted free cash flow increased 54.5%, primarily as a result of improved working capital.

Total Revenue
$1.33B
Previous year: $1.23B
+8.5%
EPS
$0.97
Previous year: $1.05
-7.6%
Net patient revenue per discharge
$20.4K
Previous year: $20K
+2.2%
Discharges
50.77K
Previous year: 47.19K
+7.6%
Gross Profit
$1.28B
Previous year: $1.18B
+8.4%
Cash and Equivalents
$94.2M
Previous year: $224M
-57.9%
Free Cash Flow
$166M
Previous year: $59.7M
+177.9%
Total Assets
$6.94B
Previous year: $6.54B
+6.1%

Encompass Health

Encompass Health

Encompass Health Revenue by Segment

Forward Guidance

The Company is reaffirming its guidance for full-year 2022.

Revenue & Expenses

Visualization of income flow from segment revenue to net income